Effects of Cytokine Administration on Human Hematopoiesis in SCID-hu Mice

[1]  J. D. de Vries,et al.  IL-4 induces human B cell maturation and IgE synthesis in SCID-hu mice. Inhibition of ongoing IgE production by in vivo treatment with an IL-4/IL-13 receptor antagonist. , 1995, Journal of immunology.

[2]  S. Jacobsen,et al.  Direct synergistic effects of interleukin-7 on in vitro myelopoiesis of human CD34+ bone marrow progenitors. , 1994, Blood.

[3]  William Vainchenker,et al.  c-Mpl ligand is a humoral regulator of megakaryocytopoiesis , 1994, Nature.

[4]  V. Broudy,et al.  Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin , 1994, Nature.

[5]  Scott R. Presnell,et al.  Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo , 1994, Nature.

[6]  D. Goeddel,et al.  Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand , 1994, Nature.

[7]  B. Ryffel,et al.  Long-term interleukin-6 administration stimulates sustained thrombopoiesis and acute-phase protein synthesis in a small primate-- the marmoset , 1994 .

[8]  J. McCune,et al.  Direct evaluation of radiation damage in human hematopoietic progenitor cells in vivo. , 1994, Radiation research.

[9]  P. Debré,et al.  CD34-expressing human thymocyte precursors proliferate in response to interleukin-7 but have lost myeloid differentiation potential. , 1993, Blood.

[10]  D. Williams,et al.  Combination protocols of cytokine therapy with interleukin-3 and granulocyte-macrophage colony-stimulating factor in a primate model of radiation-induced marrow aplasia. , 1993, Blood.

[11]  G. Bonadonna,et al.  Recombinant human interleukin-3 hastens trilineage hematopoietic recovery following high-dose (7 g/m2) cyclophosphamide cancer therapy. , 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  J. Canon,et al.  Dose-dependent interleukin-3 stimulation of thrombopoiesis and neutropoiesis in patients with small-cell lung carcinoma before and following chemotherapy: a placebo-controlled randomized phase Ib study. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  H. van Tinteren,et al.  Effects of interleukin-3 on myelosuppression induced by chemotherapy for ovarian cancer and small cell undifferentiated tumours. , 1993, British Journal of Cancer.

[14]  R. Ueda,et al.  Growth of human myeloid leukemias in the human marrow environment of SCID-hu mice. , 1993, Blood.

[15]  M. Aglietta,et al.  Interleukin-3 in vivo : kinetic of response of target cells , 1993 .

[16]  Porter Dg.  Is scid mouse research immune to ethics , 1993 .

[17]  R Storb,et al.  The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. , 1993, Blood.

[18]  Lesley J. Murray,et al.  Preclinical analysis of cytokine therapy in the SCID-hu mouse. , 1993, Blood.

[19]  T. MacVittie,et al.  Effects of combined administration of interleukin-6 and granulocyte colony-stimulating factor on recovery from radiation-induced hemopoietic aplasia. , 1993, Experimental hematology.

[20]  L. Kanz,et al.  In vivo effects of interleukin-6 on thrombopoiesis in healthy and irradiated primates [see comments] , 1992 .

[21]  M. Gascon,et al.  Recombinant glycosylated human interleukin-6 accelerates peripheral blood platelet count recovery in radiation-induced bone marrow depression in baboons. , 1992, Blood.

[22]  E. Sobiczewska,et al.  In vivo administration of interleukin 6 delays hematopoietic regeneration in sublethally irradiated mice. , 1992, Experimental hematology.

[23]  Y. Aoki,et al.  In vivo and in vitro interaction between interleukin 6 and granulocyte colony-stimulating factor in the regulation of murine hematopoiesis. , 1992, Experimental hematology.

[24]  M. Moore,et al.  Interactions among colony-stimulating factors, IL-1 beta, IL-6, and kit-ligand in the regulation of primitive murine hematopoietic cells. , 1992, Experimental hematology.

[25]  J. McCune,et al.  Implantation and maintenance of functional human bone marrow in SCID-hu mice. , 1992, Blood.

[26]  J. Banchereau,et al.  Interleukin-7 induces the proliferation of normal human B-cell precursors , 1991 .

[27]  M. Takagi,et al.  Interleukin-6 supports human megakaryocytic proliferation and differentiation in vitro. , 1991, Blood.

[28]  B. Naume,et al.  Effects of IL-7 and IL-2 on highly enriched CD56+ natural killer cells. A comparative study. , 1991, Journal of immunology.

[29]  M. Moore.  Review: Stratton Lecture 1990. Clinical implications of positive and negative hematopoietic stem cell regulators. , 1991, Blood.

[30]  K. Zsebo,et al.  Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages. , 1991, Experimental hematology.

[31]  Adesh K. Jain,et al.  Pharmacokinetics and effects of recombinant human erythropoietin after intravenous and subcutaneous injections in healthy volunteers. , 1990, Blood.

[32]  A. Ganser,et al.  Effects of recombinant human interleukin-3 on human hematopoietic progenitor and precursor cells in vivo. , 1990, Blood.

[33]  C. March,et al.  Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms , 1990, Cell.

[34]  K. Liechty,et al.  In Vivo Effect of Interleukin-6 on Cycling Status of Hematopoietic Progenitors from Adults and Neonates , 1990, Pediatric Research.

[35]  J. McCune,et al.  Long-term human hematopoiesis in the SCID-hu mouse , 1990, The Journal of experimental medicine.

[36]  A. Ganser,et al.  Effects of recombinant human interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failure. , 1990, Blood.

[37]  T. Miyawaki,et al.  Antagonistic effects of interleukin 6 and G-CSF in the later stage of human granulopoiesis in vitro. , 1990, Experimental hematology.

[38]  J. Laver,et al.  Effects of interleukin-3 on hematopoietic recovery after 5-fluorouracil or cyclophosphamide treatment of cynomolgus primates. , 1990, The Journal of clinical investigation.

[39]  M. Koury,et al.  Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. , 1990, Science.

[40]  T. Hirano,et al.  In vivo effects of recombinant human interleukin-6 in primates: stimulated production of platelets. , 1990, Blood.

[41]  M. Feldmann,et al.  Interleukin 7 is a growth factor for mature human T cells , 1990, European journal of immunology.

[42]  R. O'reilly,et al.  Effects of hematopoietic growth factors following myeloablation in a primate model. , 1990, International journal of cell cloning.

[43]  R. Armitage,et al.  Human IL-7: a novel T cell growth factor. , 1989, Journal of immunology.

[44]  G. Stamatoyannopoulos,et al.  Effects of interleukin-3 and erythropoietin on in vivo erythropoiesis and F-cell formation in primates. , 1989, Blood.

[45]  N. Nara,et al.  Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) on acute radiation hematopoietic injury in mice. , 1989, Experimental hematology.

[46]  R Storb,et al.  Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis of normal dogs and on hematopoietic recovery after otherwise lethal total body irradiation. , 1989, Blood.

[47]  P. Valent,et al.  The in vivo effects of recombinant human interleukin-3: demonstration of basophil differentiation factor, histamine-producing activity, and priming of GM-CSF-responsive progenitors in nonhuman primates. , 1989, Blood.

[48]  T. Kishimoto,et al.  The biology of interleukin-6. , 1989, Blood.

[49]  P. Schipper,et al.  Effects of human interleukin-3 on granulocytic colony-forming cells in human bone marrow. , 1989, Blood.

[50]  L. Aarden,et al.  Interleukin-6 synergizes with M-CSF in the formation of macrophage colonies from purified human marrow progenitor cells. , 1989, Blood.

[51]  R. Goodwin,et al.  Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[52]  K. Welte,et al.  Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors. , 1989, Experimental hematology.

[53]  T. Ulich,et al.  In vivo hematologic effects of recombinant interleukin-6 on hematopoiesis and circulating numbers of RBCs and WBCs. , 1989, Blood.

[54]  J. Gabrilove,et al.  Effect of Granulocyte Colony-Stimulating Factor on Neutropenia and Associated Morbidity Due to Chemotherapy for Transitional-Cell Carcinoma of the Urothelium , 1989 .

[55]  J. Ihle,et al.  Synergistic factors for stem cell proliferation: further studies of the target stem cells and the mechanism of stimulation by interleukin-1, interleukin-6, and granulocyte colony-stimulating factor. , 1988, Blood.

[56]  J. Gabrilove,et al.  Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium. , 1988, The Journal of clinical investigation.

[57]  M. Moore,et al.  Correction of canine cyclic hematopoiesis with recombinant human granulocyte colony-stimulating factor. , 1988, Blood.

[58]  P. Sehgal,et al.  Human IL-3 and GM-CSF act synergistically in stimulating hematopoiesis in primates. , 1988, Science.

[59]  I. Weissman,et al.  The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. , 1988, Science.

[60]  Y. Sonoda,et al.  Analysis in serum-free culture of the targets of recombinant human hemopoietic growth factors: interleukin 3 and granulocyte/macrophage-colony-stimulating factor are specific for early developmental stages. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[61]  H. Koeffler,et al.  Recombinant gibbon interleukin-3 acts synergistically with recombinant human G-CSF and GM-CSF in vitro. , 1988, Blood.

[62]  M. Ogawa,et al.  Synergism between interleukin-6 and interleukin-3 in supporting proliferation of human hematopoietic stem cells: comparison with interleukin-1 alpha. , 1988, Blood.

[63]  M. Green,et al.  EFFECT OF GRANULOCYTE COLONY STIMULATING FACTOR ON NEUTROPENIA INDUCED BY CYTOTOXIC CHEMOTHERAPY , 1988, The Lancet.

[64]  P. Quesenberry,et al.  Synergistic interactions between hematopoietic growth factors as detected by in vitro mouse bone marrow colony formation. , 1988, Experimental hematology.

[65]  J. Gasson,et al.  Recombinant gibbon interleukin 3 supports formation of human multilineage colonies and blast cell colonies in culture: comparison with recombinant human granulocyte-macrophage colony-stimulating factor. , 1987, Blood.

[66]  M. Moore,et al.  Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[67]  S. Clark,et al.  Growth of human hemopoietic colonies in response to recombinant gibbon interleukin 3: comparison with human recombinant granulocyte and granulocyte-macrophage colony-stimulating factor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[68]  F. Bieber,et al.  Stimulation of human hematopoietic colony formation by recombinant gibbon multi-colony-stimulating factor or interleukin 3. , 1987, The Journal of clinical investigation.

[69]  G. Stamatoyannopoulos,et al.  Stimulation of fetal hemoglobin synthesis by erythropoietin in baboons. , 1987, The New England journal of medicine.

[70]  J. Gabrilove,et al.  Activities of four purified growth factors on highly enriched human hematopoietic progenitor cells. , 1987, Blood.

[71]  K. Zsebo,et al.  In vivo stimulation of granulopoiesis by recombinant human granulocyte colony-stimulating factor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[72]  J. Gabrilove,et al.  Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates , 1987, The Journal of experimental medicine.

[73]  J. Adamson,et al.  Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. , 1987, The New England journal of medicine.

[74]  A. Yuo,et al.  Effect of human recombinant granulocyte colony-stimulating factor on hematopoietic injury in mice induced by 5-fluorouracil. , 1987, Blood.

[75]  C. Winearls,et al.  EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSIS , 1986, The Lancet.

[76]  F. Takaku,et al.  Recombinant human granulocyte colony-stimulating factor induces granulocytosis in vivo. , 1986, Japanese journal of cancer research : Gann.

[77]  Y. Ueyama,et al.  Purification and characterization of human granulocyte colony‐stimulating factor (G‐CSF). , 1986, The EMBO journal.

[78]  J. Gabrilove,et al.  Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. , 1986, Science.

[79]  N. Nicola,et al.  Proliferative effects of purified granulocyte colony‐stimulating factor (G‐CSF) on normal mouse hemopoietic cells , 1983, Journal of cellular physiology.

[80]  T. Chard,et al.  Pregnancy-specific beta-glycoprotein in complications of early pregnancy. , 1980, Lancet.

[81]  J. Stephenson,et al.  Induction of colonies of hemoglobin-synthesizing cells by erythropoietin in vitro. , 1971, Proceedings of the National Academy of Sciences of the United States of America.